Company / Free Cash Flow
Steris Free Cash Flow History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$778.0M
FY2024
5-year range
$395.0M / $778.0M
FY2020-FY2024
Trend
+26.9%
vs FY2023
Sector context
#33 of 145
Health Care
What the data says
Steris's free cash flow of $778M is higher than 77% of companies in the Health Care sector (FY2024). Improved from $395M to $778M over the past 2 years.
Based on SEC 10-K filings.
$778M in FY2024 with a 5-year CAGR of +15.7%. Top quartile in the Health Care sector.
Improved from $395M to $778M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +25.1%
- 5-Year CAGR
- +15.7%
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 23% of 145This company $778.0M Sector average $770.9M
▼
In line with sector average
Key checks
Key Insights
- 5-year CAGR of +15.7%, indicating consistent growth.
- In FY2024, free cash flow increased 26.9% year-over-year.
- Ranks #33 out of 145 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $778.0M | +26.9% |
| FY2023 | $612.9M | +55.2% |
| FY2022 | $395.0M | -0.6% |
| FY2021 | $397.2M | -11.8% |
| FY2020 | $450.4M | +19.8% |
| FY2019 | $376.0M | +7.5% |
| FY2018 | $349.8M | - |
| FY2017 | - | - |
| FY2016 | $251.2M | - |
As of FY2024 · SEC 10-K · Updated Mar 13, 2026